Moriwaki Toshikazu 森脇俊和

… Alternative Names

森脇俊和モリワキトシカズ

Less

Researcher Number	60455938
Other IDs
Affiliation (Current)	2025: 公益財団法人大原記念倉敷中央医療機構(臨床医学研究所臨床医学研究開発部), クリニカルサイエンスリサーチグループ, 研究員
Affiliation (based on the past Project Information) *help	2023: 公益財団法人大原記念倉敷中央医療機構(臨床医学研究所臨床医学研究開発部), クリニカルサイエンスリサーチグループ, 研究員 2022: 筑波大学, 医学医療系, 講師
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 炎症発癌モデル / レゴラフェニブ / 腫瘍抑制作用機序 / マルチ作用点薬剤

オルガノイド技術を用いた大腸癌に対するレゴラフェニブ効果・耐性因子の同定Principal Investigator
- Principal Investigator
  
  森脇俊和
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Clinical Research Center Kurashiki Central Hospital
  University of Tsukuba

All 2023 2022

All Journal Article

[Journal Article] Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study2023
- Author(s)
  Shiroyama Mamiko、Fukuoka Shota、Masuishi Toshiki、Takashima Atsuo、Kumekawa Yosuke、Kajiwara Takeshi、Yamazaki Kentaro、Shimada Yasuhiro、Esaki Taito、Makiyama Akitaka、Moriwaki Toshikazu
- Journal Title
  
  Scientific Reports
  
  Volume: 13 Issue: 1 Pages: 17931-17931
- DOI
  10.1038/s41598-023-45244-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07272
[Journal Article] Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis2023
- Author(s)
  Seyama Yusuke、Yamada Takeshi、Suzuki Hirosumi、Fukuda Satoshi、Tsuji Miki、Niisato Yusuke、Hirose Suguru、Yamamoto Yoshiyuki、Moriwaki Toshikazu、Hyodo Ichinosuke
- Journal Title
  
  International Cancer Conference Journal
  
  Volume: 12 Issue: 4 Pages: 268-273
- DOI
  10.1007/s13691-023-00611-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07272
[Journal Article] Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program2023
- Author(s)
  Nakamura Yoshiaki、Moriwaki Toshikazu、Wakabayashi Masashi、Ikeno Takashi、Shitara Kohei、Bando Hideaki、Tsuchihara Katsuya、Miki Izumi、Ichiki Hiroko、Ohtsu Atsushi、Yoshino Takayuki
- Journal Title
  
  JCO Precision Oncology
  
  Volume: in press Issue: 7
- DOI
  10.1200/po.22.00653
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07272
[Journal Article] Effect of massive ascites on ramucirumab pharmacokinetics in patients with gastrointestinal cancers: a population pharmacokinetic analysis2023
- Author(s)
  Kaneko Takuya、Doki Kosuke、Yamada Takeshi、Yamamoto Yoshiyuki、Moriwaki Toshikazu、Suzuki Yoshiharu、Homma Masato
- Journal Title
  
  Cancer Chemotherapy and Pharmacology
  
  Volume: 92 Issue: 4 Pages: 271-278
- DOI
  10.1007/s00280-023-04568-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K06718, KAKENHI-PROJECT-22K07272
[Journal Article] Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment2023
- Author(s)
  FUKUDA SATOSHI、NIISATO YUSUKE、TSUJI MIKI、FUKUDA SOMA、HAGIWARA YUYA、ONODA TSUBASA、SUZUKI HIROSUMI、TANGE YOSHITAKA、YAMADA TAKESHI、YAMAMOTO YOSHIYUKI、MORIWAKI TOSHIKAZU
- Journal Title
  
  Anticancer Research
  
  Volume: 43 Issue: 5 Pages: 2085-2090
- DOI
  10.21873/anticanres.16369
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07272, KAKENHI-PROJECT-22K08446
[Journal Article] Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol2022
- Author(s)
  Higashibata Takahiro、Yamamoto Yoshiyuki、Moriwaki Toshikazu、Morita Tatsuya、Nakajima Atsushi、Nagaoka Hiroka
- Journal Title
  
  Contemporary Clinical Trials Communications
  
  Volume: 29 Pages: 100967-100967
- DOI
  10.1016/j.conctc.2022.100967
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07272, KAKENHI-PROJECT-22K08446, KAKENHI-PROJECT-23K24563
[Journal Article] Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study2022
- Author(s)
  Hagiwara Yuya、Nakasya Akio、Matsumoto Toshihiko、Ikoma Tatsuki、Yamamoto Yoshiyuki、Kurioka Yusuke、Tsuduki Takao、Kajiwara Takeshi、Nishina Tomohiro、Yamashita Natsumi、Moriwaki Toshikazu、Hyodo Ichinosuke
- Journal Title
  
  Journal of Gastrointestinal Oncology
  
  Volume: 13 Issue: 6 Pages: 2769-2778
- DOI
  10.21037/jgo-22-499
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07272
[Journal Article] Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum2022
- Author(s)
  Ito Takahiko、Moriwaki Toshikazu、Shimada Yasuhiro
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 27 Issue: 9 Pages: 1450-1458
- DOI
  10.1007/s10147-022-02208-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07272
[Journal Article] Distribution of therapeutic monoclonal antibodies into ascites in advanced gastric cancer patients with peritoneal metastasis: case reports and literature review2022
- Author(s)
  Kaneko Takuya、Doki Kosuke、Yamada Takeshi、Yamamoto Yoshiyuki、Moriwaki Toshikazu、Suzuki Yoshiharu、Homma Masato
- Journal Title
  
  Cancer Chemotherapy and Pharmacology
  
  Volume: 90 Issue: 5 Pages: 421-426
- DOI
  10.1007/s00280-022-04479-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K06718, KAKENHI-PROJECT-22K07272
[Journal Article] Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)2022
- Author(s)
  Nakasya Akio、Hagiwara Yuya、Ikoma Tatsuki、Kurioka Yusuke、Matsumoto Toshihiko、Yamamoto Yoshiyuki、Tsuduki Takao、Kajiwara Takeshi、Moriwaki Toshikazu、Nishina Tomohiro、Yamashita Natsumi、Hyodo Ichinosuke
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 27 Issue: 4 Pages: 684-694
- DOI
  10.1007/s10147-022-02114-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07272

1. 土屋輝一郎 (40376786)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 土岐浩介

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

Moriwaki Toshikazu 森脇 俊和

森脇 俊和 モリワキ トシカズ

Research Projects

Research Products

Co-Researchers

オルガノイド技術を用いた大腸癌に対するレゴラフェニブ効果・耐性因子の同定Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effect of massive ascites on ramucirumab pharmacokinetics in patients with gastrointestinal cancers: a population pharmacokinetic analysis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Distribution of therapeutic monoclonal antibodies into ascites in advanced gastric cancer patients with peritoneal metastasis: case reports and literature review2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)2022

Author(s)

Journal Title

DOI

Data Source

Moriwaki Toshikazu 森脇俊和

森脇俊和モリワキトシカズ